(AP)—A drugmaker is clashing with pediatricians over new recommendations to limit use of a costly medicine for preventing serious lung problems in preemies and other high-risk children.
2 hours ago
5 / 5 (1) | 0
Microorganisms like bacteria and fungi can evade treatment by acquiring mutations in the genes targeted by antibiotics or antifungal drugs. These permanent mutations were once thought to be the only way for ...
17 hours ago
4.3 / 5 (6) | 0